Insomnia Treatment Market Synopsis:
Insomnia Treatment Market Size Was Valued at USD 3.24 Billion in 2023, and is Projected to Reach USD 5.76 Billion by 2032, Growing at a CAGR of 6.60% From 2024-2032.
Insomnia treatment is simply the segment that is involved in providing any product or service that can help copper insomniacs or those suffering from it. Sleeplessness, which takes root in conditions such as difficulty in the onset of sleep, staying awake, or early morning waking, is a global malady since it encompasses a broad category of sleep complaint. Therapies for this market include medications, prescription and OTC, CBT, lifestyle management therapies, and sleep improvement and sleep disorders therapies.
The global market for insomnia treatments is again in a state of growth on the back of increasing awareness about sleep disorders and increasing numbers of insomnia patients all over the world. Conditions like stress, depression, anxiety, and other health issues, together with challenges of the modern world that negatively affect people’s sleeping patterns, have all played a part for increasing incidences of insomnia. This has invariably created high demand for adequate treatment solutions to those realities in society. Going by different research, cross-sections of the population suffer from sleeplessness whereby about 30% of adults struggle with insomnia hence the growth of the market. As more clients go around looking for solutions, the pharmaceutical firms and other healthcare industries are employing so much capital on research to come up with the right solutions on how the problem of insomnia can be fixed.
The new market has been further fuelled by advances in digital health technologies including, mobile apps, sleep sheets, CBT-I apps among other non-invasive and inexpensive techniques compared to other treatments. Due to current advancements in telemedicine and online consultations, insomnia treatments are now offered in specific remote or underserved locations. This major shift towards personalized and technologically based offerings is likely to assume centre-stage in the sleeps disorder treatment market going forward years. Moreover, as people age, the need for insomnia medications will grow since people of a certain age face greater risks of developing sleep problems.
.webp)
Insomnia Treatment Market Trend Analysis:
Rising Popularity of Digital Therapeutics for Insomnia
-
Another important trend in the context of treatment of insomnia and the shares in the market is the raising use of digital therapeutics and technologies. With the prevalence of smart phones and wearable technology, people can now self-track their sleep and gain real time information on their sleep status.
- Sleep tracking applications, CBT-I application or other digital sleep programs, and avatars are changing the treatment of insomnia. These new therapies provide individual solutions expounding sleep problems, which can be solved with the help of treatments other than medicine. Also, DTx for insomnia is perceived as being more tolerant with fewer or no side effects hence preferred by patients who are against the traditional methods of drug treatments. So, when demand for such technologies rises, there will be more uses for research and development of the new lines of technology, the superior kinds of digital treatment of sleep quality.
Expansion in Emerging Markets and Growing Awareness
-
A new possible direction in the treatment of insomnia is amplifying the awareness of sleep disorders in the developing world. Sleep disorders are becoming a common problem for many countries in Asia-Pacific, Latin America, and Middle East due to such factors as urbanization, work pressure, and shift to new forms of living. In this case, these regions can be considered as the market with the highest unfulfilled demand for insomnia treatment products and services.
- Also, the availability of the health care services the medication is increasing in many of the emerging markets. Higher incidence of healthcare spending, especially on mental health, coupled with health-conscious initiatives by the governments would indeed put the market at the right driver’s seat. Moreover, due to the growth of the internet and mobile technology, there is increasing potential for the utility of health technologies that can help people with insomnia treatment, and, therefore, there is great potential for the digital therapeutics and teleconsultation services market.
Insomnia Treatment Market Segment Analysis:
Insomnia Treatment Market is Segmented on the basis of Treatment Type, Drug Type, End User, and Region.
By Treatment Type, Prescription Medications segment is expected to dominate the market during the forecast period
-
The market on insomnia treatment is divided into subgroups by treatment kind and consists of both medicinal and non-medicinal treatment. Another category of drugs used as sleeping medications includes prescription sleep medications, which include benzodiazepine and non-benzodiazepine hypnotics. Also, ordinary drugs such as antihistamine and melatonin tablet and syrup are affordable and temporary remedies for those in need. However, as a more credible treatment process, behavioural therapy especially CBT-I is slowly being adopted because it deals with the underlying causes of sleep disorders. It is estimated that this non-pharmacological treatment is effective in treating chronic insomnia and is the most effective treatment in place.
- Turning to non-pharmacological treatment the public looking for more mild treatments, including those and herbal and non-traditional medicine as valerian root, chamomile among others. Further, the use of sleep monitoring devices such as Wearable devices and sleep trackers allow for people to monitor and regulate their sleep monitoring or lack of in order to obtain quality data regarding their sleep. Mobile applications and other digital CBT-I products are changing the approach to insomnia treatment as they are effective, readily available, and may be adjusted for the specific user. These gizmos are progressing in appeal since they are handy, economical and can reached a vast audience especially in the developing countries where there is little to no access to therapy.
By Drug type, Benzodiazepines segment expected to held the largest share
-
Benzodiazepines include diazepam and lorazepam, which are prescribed for short term insomnia because of sedating properties but which entitle side effects and dependence. Zolpidem and eszopiclone are used frequently in practice because they are non-benzodiazepine hypnotics effective for treating acute insomnia without the consequences of dependence. Further, some drugs that are not prescribed for sleep disorders are trazodone and amitriptyline which are commonly used as antidepressants but have a knock-on effect of treating people with insomnia.
- The other class of drugs used in the treatment of insomnia includes the melatonin agonists like ramelteon, which acts in the circadian integrate to facilitate sleep-wake cycle and is particularly helpful on patients with sleep-wake rhythm disturbances. Other drugs such as quetiapine are sometimes used where other remedies have proven powerless or where the sleeplessness detected is as a result of some psychiatric conditions. There are other drugs that may be employed in managing insomnia and they include; antihistamine, sedative-hypnotic, and other OTC drugs that address some parts of insomnia. Since there are numerous kinds of drugs, the health care giver is able to choose between them depending on the symptoms and diseases, the patient contracts as well as his or her preferences.
Insomnia Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America is expected to hold the largest share of the insomnia treatment market in 2023 with a global percentage comprising mostly of United States and Canada. The United States has a significant concentration of markets for both insomnia treatment medicine and products and CBT-I.
- Also, the growth rate for stress-related disorders, changing lifestyles, and growing concerns about unhealthy sleep are also driving the growth in the insomnia treatment market within the same region. Moreover, due to the great population of consumers with advanced technology knowledge in North America, an improvement in the digital health solutions for insomnia treatments improves the overall market. The dominance of the region is expected to continue in the near future, backed by a robust health care structure and ascent in the demand for enhanced sleep.
Active Key Players in the Insomnia Treatment Market
- Akeso Inc. (USA)
- Eli Lilly and Company (USA)
- GSK plc (UK)
- Johnson & Johnson (USA)
- Kyorin Pharmaceutical Co., Ltd. (Japan)
- Lupin Pharmaceuticals (India)
- Merck & Co., Inc. (USA)
- Mylan N.V. (USA)
- Pfizer Inc. (USA)
- Sandoz (Germany)
- Sanofi (France)
- Sepracor (USA)
- Takeda Pharmaceutical Company (Japan)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Vanda Pharmaceuticals Inc. (USA)
- Other Active Players.
|
Insomnia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.24 Billion |
|
Forecast Period 2024-32 CAGR: |
6.60% |
Market Size in 2032: |
USD 5.76 Billion |
|
Segments Covered: |
By Treatment Type |
|
|
|
By Drug Type |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Insomnia Treatment Market by Treatment Type
4.1 Insomnia Treatment Market Snapshot and Growth Engine
4.2 Insomnia Treatment Market Overview
4.3 Prescription Medications
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Prescription Medications: Geographic Segmentation Analysis
4.4 Over-the-Counter (OTC) Medications
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Over-the-Counter (OTC) Medications: Geographic Segmentation Analysis
4.5 Behavioural Therapy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Behavioural Therapy: Geographic Segmentation Analysis
4.6 Cognitive Behavioural Therapy for Insomnia (CBT)
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Cognitive Behavioural Therapy for Insomnia (CBT): Geographic Segmentation Analysis
4.7 Herbal & Alternative Therapies
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Herbal & Alternative Therapies: Geographic Segmentation Analysis
4.8 Sleep Monitoring Devices
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Sleep Monitoring Devices: Geographic Segmentation Analysis
4.9 Digital Therapeutics (Apps
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Digital Therapeutics (Apps: Geographic Segmentation Analysis
4.10 Wearables)
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 Wearables): Geographic Segmentation Analysis
Chapter 5: Insomnia Treatment Market by Drug Type
5.1 Insomnia Treatment Market Snapshot and Growth Engine
5.2 Insomnia Treatment Market Overview
5.3 Benzodiazepines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Benzodiazepines: Geographic Segmentation Analysis
5.4 Non-Benzodiazepine Hypnotics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Non-Benzodiazepine Hypnotics: Geographic Segmentation Analysis
5.5 Antidepressants
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Antidepressants: Geographic Segmentation Analysis
5.6 Melatonin Agonists
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Melatonin Agonists: Geographic Segmentation Analysis
5.7 Antipsychotics
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Antipsychotics: Geographic Segmentation Analysis
5.8 Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Others: Geographic Segmentation Analysis
Chapter 6: Insomnia Treatment Market by End User
6.1 Insomnia Treatment Market Snapshot and Growth Engine
6.2 Insomnia Treatment Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation Analysis
6.5 Homecare Settings
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Homecare Settings: Geographic Segmentation Analysis
6.6 Online Platforms
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Online Platforms: Geographic Segmentation Analysis
6.7 Telemedicine
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Telemedicine: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Insomnia Treatment Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 AKESO INC. (USA)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ELI LILLY AND COMPANY (USA)
7.4 GSK PLC (UK)
7.5 JOHNSON & JOHNSON (USA)
7.6 KYORIN PHARMACEUTICAL CO. LTD. (JAPAN)
7.7 LUPIN PHARMACEUTICALS (INDIA)
7.8 MERCK & CO. INC. (USA)
7.9 MYLAN N.V. (USA)
7.10 PFIZER INC. (USA)
7.11 SANOFI (FRANCE)
7.12 SANDOZ (GERMANY)
7.13 SEPRACOR (USA)
7.14 TAKEDA PHARMACEUTICAL COMPANY (JAPAN)
7.15 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.16 VANDA PHARMACEUTICALS INC. (USA)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Insomnia Treatment Market By Region
8.1 Overview
8.2. North America Insomnia Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Treatment Type
8.2.4.1 Prescription Medications
8.2.4.2 Over-the-Counter (OTC) Medications
8.2.4.3 Behavioural Therapy
8.2.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.2.4.5 Herbal & Alternative Therapies
8.2.4.6 Sleep Monitoring Devices
8.2.4.7 Digital Therapeutics (Apps
8.2.4.8 Wearables)
8.2.5 Historic and Forecasted Market Size By Drug Type
8.2.5.1 Benzodiazepines
8.2.5.2 Non-Benzodiazepine Hypnotics
8.2.5.3 Antidepressants
8.2.5.4 Melatonin Agonists
8.2.5.5 Antipsychotics
8.2.5.6 Others
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Clinics
8.2.6.3 Homecare Settings
8.2.6.4 Online Platforms
8.2.6.5 Telemedicine
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Insomnia Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Treatment Type
8.3.4.1 Prescription Medications
8.3.4.2 Over-the-Counter (OTC) Medications
8.3.4.3 Behavioural Therapy
8.3.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.3.4.5 Herbal & Alternative Therapies
8.3.4.6 Sleep Monitoring Devices
8.3.4.7 Digital Therapeutics (Apps
8.3.4.8 Wearables)
8.3.5 Historic and Forecasted Market Size By Drug Type
8.3.5.1 Benzodiazepines
8.3.5.2 Non-Benzodiazepine Hypnotics
8.3.5.3 Antidepressants
8.3.5.4 Melatonin Agonists
8.3.5.5 Antipsychotics
8.3.5.6 Others
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Clinics
8.3.6.3 Homecare Settings
8.3.6.4 Online Platforms
8.3.6.5 Telemedicine
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Insomnia Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Treatment Type
8.4.4.1 Prescription Medications
8.4.4.2 Over-the-Counter (OTC) Medications
8.4.4.3 Behavioural Therapy
8.4.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.4.4.5 Herbal & Alternative Therapies
8.4.4.6 Sleep Monitoring Devices
8.4.4.7 Digital Therapeutics (Apps
8.4.4.8 Wearables)
8.4.5 Historic and Forecasted Market Size By Drug Type
8.4.5.1 Benzodiazepines
8.4.5.2 Non-Benzodiazepine Hypnotics
8.4.5.3 Antidepressants
8.4.5.4 Melatonin Agonists
8.4.5.5 Antipsychotics
8.4.5.6 Others
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Clinics
8.4.6.3 Homecare Settings
8.4.6.4 Online Platforms
8.4.6.5 Telemedicine
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Insomnia Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Treatment Type
8.5.4.1 Prescription Medications
8.5.4.2 Over-the-Counter (OTC) Medications
8.5.4.3 Behavioural Therapy
8.5.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.5.4.5 Herbal & Alternative Therapies
8.5.4.6 Sleep Monitoring Devices
8.5.4.7 Digital Therapeutics (Apps
8.5.4.8 Wearables)
8.5.5 Historic and Forecasted Market Size By Drug Type
8.5.5.1 Benzodiazepines
8.5.5.2 Non-Benzodiazepine Hypnotics
8.5.5.3 Antidepressants
8.5.5.4 Melatonin Agonists
8.5.5.5 Antipsychotics
8.5.5.6 Others
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Clinics
8.5.6.3 Homecare Settings
8.5.6.4 Online Platforms
8.5.6.5 Telemedicine
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Insomnia Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Treatment Type
8.6.4.1 Prescription Medications
8.6.4.2 Over-the-Counter (OTC) Medications
8.6.4.3 Behavioural Therapy
8.6.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.6.4.5 Herbal & Alternative Therapies
8.6.4.6 Sleep Monitoring Devices
8.6.4.7 Digital Therapeutics (Apps
8.6.4.8 Wearables)
8.6.5 Historic and Forecasted Market Size By Drug Type
8.6.5.1 Benzodiazepines
8.6.5.2 Non-Benzodiazepine Hypnotics
8.6.5.3 Antidepressants
8.6.5.4 Melatonin Agonists
8.6.5.5 Antipsychotics
8.6.5.6 Others
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Clinics
8.6.6.3 Homecare Settings
8.6.6.4 Online Platforms
8.6.6.5 Telemedicine
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Insomnia Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Treatment Type
8.7.4.1 Prescription Medications
8.7.4.2 Over-the-Counter (OTC) Medications
8.7.4.3 Behavioural Therapy
8.7.4.4 Cognitive Behavioural Therapy for Insomnia (CBT)
8.7.4.5 Herbal & Alternative Therapies
8.7.4.6 Sleep Monitoring Devices
8.7.4.7 Digital Therapeutics (Apps
8.7.4.8 Wearables)
8.7.5 Historic and Forecasted Market Size By Drug Type
8.7.5.1 Benzodiazepines
8.7.5.2 Non-Benzodiazepine Hypnotics
8.7.5.3 Antidepressants
8.7.5.4 Melatonin Agonists
8.7.5.5 Antipsychotics
8.7.5.6 Others
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Clinics
8.7.6.3 Homecare Settings
8.7.6.4 Online Platforms
8.7.6.5 Telemedicine
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Insomnia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.24 Billion |
|
Forecast Period 2024-32 CAGR: |
6.60% |
Market Size in 2032: |
USD 5.76 Billion |
|
Segments Covered: |
By Treatment Type |
|
|
|
By Drug Type |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
